Association of Lipid Fractions With Risks for Coronary Artery Disease and Diabetes

被引:231
作者
White, Jon [3 ]
Swerdlow, Daniel I. [4 ,5 ]
Preiss, David [1 ,2 ]
Fairhurst-Hunter, Zammy [6 ]
Keating, Brendan J. [7 ,8 ]
Asselbergs, FolkertW. [9 ,10 ,11 ]
Sattar, Naveed [12 ]
Humphries, Steve E. [13 ]
Hingorani, Aroon D. [4 ,11 ]
Holmes, Michael V. [1 ,2 ]
机构
[1] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Roosevelt Dr,Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England
[2] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit, Roosevelt Dr,Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England
[3] UCL, Genet Inst, London, England
[4] UCL, Farr Inst, London, England
[5] Imperial Coll London, Dept Med, London, England
[6] Univ Oxford, Wellcome Trust, Ctr Human Genet, Oxford, England
[7] Childrens Hosp Philadelphia, Ctr Appl Gen, Philadelphia, PA 19104 USA
[8] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA
[9] Univ Med Ctr Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands
[10] Netherlands Heart Inst, Durrer Ctr Cardiovasc Res, Utrecht, Netherlands
[11] UCL, Inst Cardiovasc Sci, London, England
[12] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[13] UCL, Cardiovasc Genet, British Heart Fdn Labs, Inst Cardiovasc Sci, London, England
基金
英国惠康基金;
关键词
MULTIVARIABLE MENDELIAN RANDOMIZATION; PLEIOTROPIC GENETIC-VARIANTS; STATIN THERAPY; LDL CHOLESTEROL; PLASMA TRIGLYCERIDES; CARDIOVASCULAR RISK; METAANALYSIS; EFFICACY; EPIDEMIOLOGY; INSTRUMENTS;
D O I
10.1001/jamacardio.2016.1884
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Low-density lipoprotein cholesterol (LDL-C) is causally related to coronary artery disease (CAD), but the relevance of high-density lipoprotein cholesterol (HDL-C) and triglycerides (TGs) is uncertain. Lowering of LDL-C levels by statin therapy modestly increases the risk of type 2 diabetes, but it is unknown whether this effect is specific to statins. OBJECTIVE To investigate the associations of 3 routinely measured lipid fractions with CAD and diabetes through mendelian randomization (MR) using conventional MR and making use of newer approaches, such as multivariate MR and MR-Egger, that address the pleiotropy of genetic instruments where relevant. DESIGN, SETTING, AND PARTICIPANTS Published data from genome-wide association studies were used to construct genetic instruments and then applied to investigate associations between lipid fractions and the risk of CAD and diabetes using MR approaches that took into account pleiotropy of genetic instruments. The study was conducted from March 12 to December 31, 2015. MAIN OUTCOMES AND MEASURES Coronary artery disease and diabetes. RESULTS Genetic instruments composed of 130 single-nucleotide polymorphisms (SNPs) were used for LDL-C (explaining 7.9% of its variance), 140 SNPs for HDL-C (6.6% of variance), and 140 SNPs for TGs (5.9% of variance). A 1-SD genetically instrumented elevation in LDL-C levels (equivalent to 38 mg/dL) and TG levels (equivalent to 89 mg/dL) was associated with higher CAD risk; odds ratios (ORs) were 1.68 (95% CI, 1.51-1.87) for LDL-C and 1.28 (95% CI, 1.13-1.45) for TGs. The corresponding OR for HDL-C (equivalent to a 16-mg/dL increase) was 0.95 (95% CI, 0.85-1.06). All 3 lipid traits were associated with a lower risk of type 2 diabetes. The ORs were 0.79 (95% CI, 0.71-0.88) for LDL-C and 0.83 (95% CI, 0.76-0.90) for HDL-C per 1-SD elevation. For TG, the MR estimates for diabetes were inconsistent, with MR-Egger giving an OR of 0.83 (95% CI, 0.72-0.95) per 1-SD elevation. CONCLUSIONS AND RELEVANCE Routinely measured lipid fractions exhibit contrasting associations with the risk of CAD and diabetes. Increased LDL-C, HDL-C, and possibly TG levels are associated with a lower risk of diabetes. This information will be relevant to the design of clinical trials of lipid-modifying agents, which should carefully monitor participants for dysglycemia and the incidence of diabetes.
引用
收藏
页码:692 / 699
页数:8
相关论文
共 35 条
[1]   Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy [J].
Akdim, Fatima ;
Stroes, Erik S. G. ;
Sijbrands, Eric J. G. ;
Tribble, Diane L. ;
Trip, Mieke D. ;
Jukema, J. Wouter ;
Flaim, JoAnn D. ;
Su, John ;
Yu, Rosie ;
Baker, Brenda F. ;
Wedel, Mark K. ;
Kastelein, John J. P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (15) :1611-1618
[2]   Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials [J].
Baigent, C. ;
Blackwell, L. ;
Emberson, J. ;
Holland, L. E. ;
Reith, C. ;
Bhala, N. ;
Peto, R. ;
Barnes, E. H. ;
Keech, A. ;
Simes, J. ;
Collins, R. .
LANCET, 2010, 376 (9753) :1670-1681
[3]   The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis [J].
Bonnefond, Amelie ;
Yengo, Loic ;
Le May, Cedric ;
Fumeron, Frederic ;
Marre, Michel ;
Balkau, Beverley ;
Charpentier, Guillaume ;
Franc, Sylvia ;
Froguel, Philippe ;
Cariou, Bertrand .
DIABETOLOGIA, 2015, 58 (09) :2051-2055
[4]   Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression [J].
Bowden, Jack ;
Smith, George Davey ;
Burgess, Stephen .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 (02) :512-525
[5]   Calculating statistical power in Mendelian randomization studies [J].
Brion, Marie-Jo A. ;
Shakhbazov, Konstantin ;
Visscher, Peter M. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2013, 42 (05) :1497-1501
[6]   RE: "MULTIVARIABLE MENDELIAN RANDOMIZATION: THE USE OF PLEIOTROPIC GENETIC VARIANTS TO ESTIMATE CAUSAL EFFECTS" [J].
Burgess, Stephen ;
Dudbridge, Frank ;
Thompson, Simon G. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2015, 181 (04) :290-291
[7]  
Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283
[8]   Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes [J].
Cannon, Christopher P. ;
Blazing, Michael A. ;
Giugliano, Robert P. ;
McCagg, Amy ;
White, Jennifer A. ;
Theroux, Pierre ;
Darius, Harald ;
Lewis, Basil S. ;
Ophuis, Ton Oude ;
Jukema, J. Wouter ;
De Ferrari, Gaetano M. ;
Ruzyllo, Witold ;
De Lucca, Paul ;
Im, KyungAh ;
Bohula, Erin A. ;
Reist, Craig ;
Wiviott, Stephen D. ;
Tershakovec, Andrew M. ;
Musliner, Thomas A. ;
Braunwald, Eugene ;
Califf, Robert M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (25) :2387-2397
[9]   A Robust Example of Collider Bias in a Genetic Association Study [J].
Day, Felix R. ;
Loh, Po-Ru ;
Scott, Robert A. ;
Ong, Ken K. ;
Perry, John R. B. .
AMERICAN JOURNAL OF HUMAN GENETICS, 2016, 98 (02) :392-393
[10]   Large-scale association analysis identifies new risk loci for coronary artery disease [J].
Deloukas, Panos ;
Kanoni, Stavroula ;
Willenborg, Christina ;
Farrall, Martin ;
Assimes, Themistocles L. ;
Thompson, John R. ;
Ingelsson, Erik ;
Saleheen, Danish ;
Erdmann, Jeanette ;
Goldstein, Benjamin A. ;
Stirrups, Kathleen ;
Koenig, Inke R. ;
Cazier, Jean-Baptiste ;
Johansson, Asa ;
Hall, Alistair S. ;
Lee, Jong-Young ;
Willer, Cristen J. ;
Chambers, John C. ;
Esko, Tonu ;
Folkersen, Lasse ;
Goel, Anuj ;
Grundberg, Elin ;
Havulinna, Aki S. ;
Ho, Weang K. ;
Hopewell, Jemma C. ;
Eriksson, Niclas ;
Kleber, Marcus E. ;
Kristiansson, Kati ;
Lundmark, Per ;
Lyytikainen, Leo-Pekka ;
Rafelt, Suzanne ;
Shungin, Dmitry ;
Strawbridge, Rona J. ;
Thorleifsson, Gudmar ;
Tikkanen, Emmi ;
Van Zuydam, Natalie ;
Voight, Benjamin F. ;
Waite, Lindsay L. ;
Zhang, Weihua ;
Ziegler, Andreas ;
Absher, Devin ;
Altshuler, David ;
Balmforth, Anthony J. ;
Barroso, Ines ;
Braund, Peter S. ;
Burgdorf, Christof ;
Claudi-Boehm, Simone ;
Cox, David ;
Dimitriou, Maria ;
Do, Ron .
NATURE GENETICS, 2013, 45 (01) :25-U52